Tectonic Therapeutic Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tectonic Therapeutic (TECX).

Price Target Range — 9 Quarters

Analyst Consensus — 10 Analysts

1S.Buy

9Buy

Consensus RatingOutperform# Analysts10Avg. Consensus PT$77Upside to Avg. PT+229.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Wells Fargo	Tiago Fauth	PT Cut	Overweight	$101→$93
May 26, 2026	Raymond James	Michael Freeman	Upgrade	Outperform→Strong Buy	$76→$81
Apr 14, 2026	Stifel	James Condulis	Initiate	Buy	$75
Jan 8, 2026	Truist Securities	Danielle Brill	PT Cut	Buy	$64→$60
Sep 3, 2025	Oppenheimer	Leland Gershell	Initiate	Outperform	$80
Jul 21, 2025	Truist Securities	Danielle Brill	Initiate	Buy	$64
Jun 11, 2025	Raymond James	Michael Freeman	Reinstates	Outperform	$76
Jun 6, 2025	LifeSci Capital	—	Initiate	Outperform	$87
May 15, 2025	Mizuho	Uy Ear	PT Raise	Outperform	$51→$85
Apr 21, 2025	Mizuho	Uy Ear	Initiate	Outperform	$51
Mar 21, 2025	Wells Fargo	Tiago Fauth	PT Cut	Overweight	$112→$101
Jan 31, 2025	Wells Fargo	Tiago Fauth	PT Raise	Overweight	$79→$112
Nov 20, 2024	Raymond James	Danielle Brill	Initiate	Outperform	$65
Nov 12, 2024	Wells Fargo	Tiago Fauth	PT Raise	Overweight	$55→$79
Nov 11, 2024	Leerink Partners	David Risinger	PT Raise	Outperform	$49→$69
Aug 22, 2024	Wells Fargo	Tiago Fauth	Initiate	Overweight	$55
Jul 24, 2024	Leerink Partners	David Risinger	Initiate	Outperform	$49
Jun 26, 2024	Piper Sandler	Yasmeen Rahimi	Initiate	Overweight	$76
Jun 24, 2024	TD Cowen	Tyler Van Buren	Initiate	Buy	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.

Benzinga Newsdesk

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.

Benzinga Newsdesk

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy and lowers the price target from $64 to $60.

Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $80.

Benzinga Newsdesk

PRO
Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $64.

Benzinga Newsdesk

Tectonic Therapeutic Inc

Tectonic Therapeutic Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

PRO
Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64

People Also Watch

People Also Watch

Tectonic Therapeutic Inc

Tectonic Therapeutic Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRORaymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PROStifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PROTruist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PROOppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

PROTruist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64

People Also Watch

People Also Watch

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

PRO
Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64